Optical control of neuromodulatory GPCRs
神经调节 GPCR 的光学控制
基本信息
- 批准号:10012228
- 负责人:
- 金额:$ 326.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsAdrenergic AgentsAgonistArrestinsAtlasesAttentionAxonBehaviorBehavioralBindingBinding SitesBrain regionCellsChemicalsChemistryCognitionCommunitiesCorpus striatum structureCoupledCouplingDRD2 geneDendritesDesire for foodDiseaseDopamineDopamine ReceptorElectron Transport Complex IIIElectrophysiology (science)EpitopesEquilibriumFamilyFinancial compensationG-Protein-Coupled ReceptorsGABA-B ReceptorGTP-Binding ProteinsGene DeliveryGenesGlutamate ReceptorGoalsHistocytochemistryImageImmunologic TestsInjectionsKnock-outLabelLeadLearningLengthLigand BindingLigand Binding DomainLigandsLightLocationLocomotionMembraneMetabotropic Glutamate ReceptorsMood DisordersMotorMusNeuromodulatorNeuronsNeuropsychologyNeurosciencesOpticsPathway interactionsPatternPharmaceutical PreparationsPharmacologyPhysiologicalPlayProcessReceptor CellRewardsRoleSchizophreniaSignal TransductionSleepSliceSpecificitySystemTestingTimeTransgenic AnimalsValidationViralWorkadeno-associated viral vectorapproach avoidance behaviorbrain behaviorcell typecholinergicdesigner receptors exclusively activated by designer drugsextracellularfluorophoregenetic manipulationin vivoinsightknockout genemotor controlneuroregulationnovel strategiesoperationoptogeneticsprotein biomarkerspsychologicreceptorreceptor functionremote controlspatiotemporalstoichiometrysubcellular targetingsuccesstoolvector
项目摘要
SUMMARY/ABSTRACT
A major goal of neuroscience is to understand how neuromodulatory systems regulate core processes of brain
and behavior, from motor function and learning to reward, aversion, attention, and sleep. These systems go
awry in schizophrenia and disorders of mood, motor control and cognition. Treatment for these conditions often
turns to pharmacological manipulation of neuromodulators and their receptors. Understanding of
neuromodulatory circuits has advanced considerably thanks to optogenetics and chemogenetics. But
neuromodulation is difficult to crack. A major obstacle is that a single neuromodulator may play many diverse
roles because it has multiple receptors, with different functions in different cell locations and different cells
within a circuit. Unfortunately, drugs and genetic manipulations cannot typically be targeted or controlled with
sufficient spatio-temporal precision to unravel these different functions. We are developing two approaches
that provide the needed precision by controlling native, full-length neuromodulatory receptors with
photoswitchable tethered ligands (PTLs). Preliminary Iwork demonstrates feasibility of both approaches as
applied to two core neuromodulatory receptor families: metabotropic glutamate receptors (mGluRs) and
dopamine receptors (DARs). In this proposal, we optimize and expands an approach in which we directly
attach PTLs to a specific receptor subtype and develop a new approach that does not touch those receptors,
but deliver the PTL to them on a membrane anchor. Because the membrane anchor can be targeted to specific
locations within the cell, it can selectively control receptors only at that location, and it can use either broad
ligands (which hit all local receptors of that type) or highly selective ligands (to control only one subtype at a
time). The tools will be demonstrated in mice and provided to the community as gene delivery vectors, PTLs
and transgenic animal lines.
总结/摘要
神经科学的一个主要目标是了解神经调节系统如何调节大脑的核心过程
和行为,从运动功能和学习到奖励,厌恶,注意力和睡眠。这些系统
在精神分裂症和情绪、运动控制和认知障碍中出现偏差。这些疾病的治疗通常
转向神经调质及其受体的药理学操作。了解
由于光遗传学和化学遗传学,神经调节回路已经有了相当大的进步。但
神经调节很难破解一个主要的障碍是一个单一的神经调质可能发挥许多不同的作用,
因为它有多种受体,在不同的细胞位置和不同的细胞中具有不同的功能,
在一个电路中。不幸的是,药物和基因操作通常不能被靶向或控制,
足够的时空精度来解开这些不同的功能。我们正在开发两种方法
通过控制天然的全长神经调节受体来提供所需的精确度,
光可转换的栓系配体(PTL)。初步工作证明了这两种方法的可行性,
应用于两个核心神经调节受体家族:代谢型谷氨酸受体(mGluRs)和
多巴胺受体(DARs)。在这项提案中,我们优化和扩展了一种方法,
将PTL连接到特定的受体亚型上,并开发出一种不接触这些受体的新方法,
而是在膜锚上将PTL递送给它们。因为膜锚可以靶向特定的
在细胞内的位置,它可以选择性地控制受体只在该位置,它可以使用或广泛的
配体(其击中该类型的所有局部受体)或高选择性配体(以在一个时间点上仅控制一种亚型)。
时间)。这些工具将在小鼠中进行演示,并作为基因传递载体(PTL)提供给社区。
和转基因动物品系。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors.
- DOI:10.1038/s41467-021-25003-w
- 发表时间:2021-08-06
- 期刊:
- 影响因子:16.6
- 作者:Donthamsetti P;Winter N;Hoagland A;Stanley C;Visel M;Lammel S;Trauner D;Isacoff E
- 通讯作者:Isacoff E
Selective Photoswitchable Allosteric Agonist of a G Protein-Coupled Receptor.
- DOI:10.1021/jacs.1c02586
- 发表时间:2021-06-23
- 期刊:
- 影响因子:15
- 作者:Donthamsetti P;Konrad DB;Hetzler B;Fu Z;Trauner D;Isacoff EY
- 通讯作者:Isacoff EY
Mesoaccumbal Dopamine Heterogeneity: What Do Dopamine Firing and Release Have to Do with It?
- DOI:10.1146/annurev-neuro-110920-011929
- 发表时间:2022-07-08
- 期刊:
- 影响因子:13.9
- 作者:
- 通讯作者:
Homo- and hetero-dimeric subunit interactions set affinity and efficacy in metabotropic glutamate receptors.
- DOI:10.1038/s41467-023-44013-4
- 发表时间:2023-12-13
- 期刊:
- 影响因子:16.6
- 作者:Habrian, Chris;Latorraca, Naomi;Fu, Zhu;Isacoff, Ehud Y.
- 通讯作者:Isacoff, Ehud Y.
Domain coupling in activation of a family C GPCR.
C 族 GPCR 激活中的域偶联。
- DOI:10.1101/2024.02.28.582567
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Latorraca,NaomiR;Sabaat,Sam;Habrian,Chris;Bleier,Julia;Stanley,Cherise;Marqusee,Susan;Isacoff,EhudY
- 通讯作者:Isacoff,EhudY
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ehud Isacoff其他文献
Ehud Isacoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ehud Isacoff', 18)}}的其他基金
Conformational mechanisms of mGluR gating and regulation
mGluR 门控和调节的构象机制
- 批准号:
10298420 - 财政年份:2021
- 资助金额:
$ 326.39万 - 项目类别:
Conformational mechanisms of mGluR gating and regulation
mGluR 门控和调节的构象机制
- 批准号:
10665636 - 财政年份:2021
- 资助金额:
$ 326.39万 - 项目类别:
Conformational mechanisms of mGluR gating and regulation
mGluR 门控和调节的构象机制
- 批准号:
10443878 - 财政年份:2021
- 资助金额:
$ 326.39万 - 项目类别:
Synaptic to circuit homeostasis in the Drosophila locomotor system
果蝇运动系统中的突触与电路稳态
- 批准号:
10654556 - 财政年份:2019
- 资助金额:
$ 326.39万 - 项目类别:
Synaptic to circuit homeostasis in the Drosophila locomotor system
果蝇运动系统中的突触与电路稳态
- 批准号:
10438585 - 财政年份:2019
- 资助金额:
$ 326.39万 - 项目类别:
Synaptic to circuit homeostasis in the Drosophila locomotor system
果蝇运动系统中的突触与电路稳态
- 批准号:
10210452 - 财政年份:2019
- 资助金额:
$ 326.39万 - 项目类别:
Novel tools for cell-specific imaging of functional connectivity and circuit operations
用于功能连接和电路操作的细胞特异性成像的新工具
- 批准号:
9343283 - 财政年份:2015
- 资助金额:
$ 326.39万 - 项目类别:
Novel tools for cell-specific imaging of functional connectivity and circuit operations
用于功能连接和电路操作的细胞特异性成像的新工具
- 批准号:
9036880 - 财政年份:2015
- 资助金额:
$ 326.39万 - 项目类别:
Optical control of synaptic transmission for in vivo analysis of brain circuits and behavior
突触传递的光学控制用于脑回路和行为的体内分析
- 批准号:
8934227 - 财政年份:2014
- 资助金额:
$ 326.39万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 326.39万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 326.39万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 326.39万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 326.39万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 326.39万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 326.39万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 326.39万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 326.39万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 326.39万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 326.39万 - 项目类别:














{{item.name}}会员




